PATENT CLAIM ANALYSIS

Application Number: 15876821
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "04400R"]

Abstract:
Expression vectors and therapeutic methods of using such vectors in the treatment of diseases of the eye resulting from failure to produce a specific protein in the eye, or the production of a non-functional protein in the eye.

Claim (Index 10):
The method of  claim 1 , wherein the method further comprises administering the expression vector in combination with one or more additional active agents or supportive therapies for treating, preventing, or reducing the severity of the eye disorder, disease, or injury.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.53846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14766842', '14660657', '12366596', '13212078', '13388083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7226724230585813
- 35 USC 102 Novelty (BERT): 0.5806116179773992
- Combined Prediction Score: 0.708466342550463
- Mean Citation Score: 352.866614
- Max Citation Score: 571.0919
- Similarity Product: 336.63543163319827

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test